C203H273F3N26O16 — CID 161089607
N-[6-[(4,4-difluoropiperidin-1-yl)methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]-4-methylbenzamide;N-[6-[[4-(ethylaminomethyl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]-4-methylbenzamide;3-fluoro-N-[6-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]-5-methylbenzamide;N-[6-[[4-(1-hydroxyethyl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]-4-methylbenzamide;N-[6-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;N-[6-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]pyridine-3-carboxamide (PubChem CID 161089607) has the molecular formula C203H273F3N26O16 and a molecular weight of 3390.58 g/mol. Its IUPAC name is N-[6-[(4,4-difluoropiperidin-1-yl)methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]-4-methylbenzamide;N-[6-[[4-(ethylaminomethyl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]-4-methylbenzamide;3-fluoro-N-[6-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]-5-methylbenzamide;N-[6-[[4-(1-hydroxyethyl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]-4-methylbenzamide;N-[6-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;N-[6-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]pyridine-3-carboxamide.
| Compound Name | N-[6-[(4,4-difluoropiperidin-1-yl)methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]-4-methylbenzamide;N-[6-[[4-(ethylaminomethyl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]-4-methylbenzamide;3-fluoro-N-[6-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]-5-methylbenzamide;N-[6-[[4-(1-hydroxyethyl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]-4-methylbenzamide;N-[6-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;N-[6-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]pyridine-3-carboxamide |
|---|---|
| PubChem CID | 161089607 |
| Molecular Formula | C203H273F3N26O16 |
| Molecular Weight | 3390.58 g/mol |
| Exact Mass | 3388.13 |
| IUPAC Name | N-[6-[(4,4-difluoropiperidin-1-yl)methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]-4-methylbenzamide;N-[6-[[4-(ethylaminomethyl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]-4-methylbenzamide;3-fluoro-N-[6-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]-5-methylbenzamide;N-[6-[[4-(1-hydroxyethyl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]-4-methylbenzamide;N-[6-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]benzamide;N-[6-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]-3H-indol-2-ylidene]pyridine-3-carboxamide |
| SMILES | CC(C)NC(=O)C1CCC(N2/C(=N/C(=O)c3ccccc3)Cc3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1.CC(C)NC(=O)C1CCC(N2/C(=N/C(=O)c3cccnc3)Cc3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1.CCNCC1CCN(Cc2ccc3c(c2)N(C2CCC(C(=O)NC(C)C)CC2)/C(=N/C(=O)c2ccc(C)cc2)C3)CC1.Cc1cc(F)cc(C(=O)/N=C2\Cc3ccc(CN4CCC(C(C)(C)O)CC4)cc3N2C2CCC(C(=O)NC(C)C)CC2)c1.Cc1ccc(C(=O)/N=C2\Cc3ccc(CN4CCC(C(C)O)CC4)cc3N2C2CCC(C(=O)NC(C)C)CC2)cc1.Cc1ccc(C(=O)/N=C2\Cc3ccc(CN4CCC(F)(F)CC4)cc3N2C2CCC(C(=O)NC(C)C)CC2)cc1 |
| InChI | InChI=1S/C35H47FN4O3.C35H49N5O2.2C34H46N4O3.C33H45N5O3.C32H40F2N4O2/c1-22(2)37-33(41)25-8-10-30(11-9-25)40-31-18-24(21-39-14-12-28(13-15-39)35(4,5)43)6-7-26(31)20-32(40)38-34(42)27-16-23(3)17-29(36)19-27;1-5-36-22-26-16-18-39(19-17-26)23-27-8-11-30-21-33(38-35(42)28-9-6-25(4)7-10-28)40(32(30)20-27)31-14-12-29(13-15-31)34(41)37-24(2)3;1-22(2)35-33(40)28-11-13-30(14-12-28)38-31-19-25(21-37-17-15-26(16-18-37)24(4)39)7-10-29(31)20-32(38)36-34(41)27-8-5-23(3)6-9-27;1-23(2)35-32(39)26-12-14-29(15-13-26)38-30-20-24(22-37-18-16-28(17-19-37)34(3,4)41)10-11-27(30)21-31(38)36-33(40)25-8-6-5-7-9-25;1-22(2)35-31(39)24-9-11-28(12-10-24)38-29-18-23(21-37-16-13-27(14-17-37)33(3,4)41)7-8-25(29)19-30(38)36-32(40)26-6-5-15-34-20-26;1-21(2)35-30(39)25-10-12-27(13-11-25)38-28-18-23(20-37-16-14-32(33,34)15-17-37)6-9-26(28)19-29(38)36-31(40)24-7-4-22(3)5-8-24/h6-7,16-19,22,25,28,30,43H,8-15,20-21H2,1-5H3,(H,37,41);6-11,20,24,26,29,31,36H,5,12-19,21-23H2,1-4H3,(H,37,41);5-10,19,22,24,26,28,30,39H,11-18,20-21H2,1-4H3,(H,35,40);5-11,20,23,26,28-29,41H,12-19,21-22H2,1-4H3,(H,35,39);5-8,15,18,20,22,24,27-28,41H,9-14,16-17,19,21H2,1-4H3,(H,35,39);4-9,18,21,25,27H,10-17,19-20H2,1-3H3,(H,35,39)/b38-32+;38-33+;36-32+;36-31+;36-30+;36-29+ |
| InChIKey | UGZNTGAXDAHNIG-IJYDZRLYSA-N |
| XLogP | 32.59 |
| TPSA | 495.90 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 43 |
| Heavy Atoms | 248 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3390.58 |
| LogP ≤ 5 | 32.59 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 24 |
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|